EXHIBIT 31.1.

      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
            PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

                                  CERTIFICATION

I,  Ronald L. Wheet,  Chief  Executive  Officer  (and  principal  financial
officer) of Revolutions Medical Corporation (formerly Maxxon, Inc.), certify
that:

     1.   I have  reviewed  this  annual  report on Form  10-KSB of Revolutions
Medical Corporation (formerly Maxxon, Inc.);

     2.   Based on my  knowledge,  this  report  does  not  contain  any  untrue
statement  of a  material  fact  or  omit to  state  a  material  fact necessary
to make the statements  made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
report;

     3.   Based on my knowledge,  the financial statements,  and other financial
information  included in this report,  fairly  present in all material respects
the financial condition, results of operations and cash flows of the small
business issuer as of, and for, the periods  presented in this report;

     4.   I am responsible for establishing and maintaining  disclosure controls
and  procedures  (as  defined  in  Exchange  Act Rules  13a-15(e)  and
15d-15(e)) for the small business issuer and have:

          (a)  Designed such disclosure controls and procedures,  or caused such
disclosure  controls  and  procedures  to be  designed  under  my supervision,
to ensure that material information relating to the small business issuer,
including its consolidated  subsidiaries,  is made known to me by others within
those entities, particularly during the period in which this report is being
prepared;

          (b)  Evaluated  the  effectiveness  of  the  small  business  issuer's
disclosure  controls and  procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and  procedures,  as of the
end of the  period  covered  by this report based on such evaluation; and

          (c)  Disclosed  in  this  report  any  change  in the  small  business
issuer's internal control over financial  reporting that occurred during the
small business issuer's fourth fiscal quarter that has materially  affected,  or
is  reasonably  likely  to  materially affect,   the  small  business  issuer's
internal  control  over financial reporting; and

     5.   I have  disclosed,  based on my most  recent  evaluation  of  internal
control  over  financial  reporting,  to the small  business  issuer's auditors
and the audit committee of the small business  issuer's board of directors (or
persons performing the equivalent functions):

          (a)  All  significant  deficiencies  and  material  weaknesses  in the
design or operation of internal control over financial  reporting which  are
reasonably  likely  to  adversely  affect  the  small business  issuer's
ability to  record,  process,  summarize  and report financial information; and

          (b)  Any fraud,  whether or not material,  that involves management or
other employees who have a significant role in the small business issuer's
internal control over financial reporting.


April 13, 2007                          /s/ RONDALD L. WHEET
                                        -----------------------------------
                                        Rondald L. Wheet,
                                        Chief Executive Officer and
                                        principal financial officer